Merck
$126.14-1.36Capitalisation boursière
$335.5B
Rang mondial
#42
Sommet historique
$335.5B
2026-08-17
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 89% of the 367 companies we track (globally).
- Equivalent to 1.1% of United States's GDP (2025 data).
- Just above: #41 The Home Depot, Inc. ($336.9B)
- Just below: #43 Procter & Gamble (P&G) ($333.3B)
- Best year: 1995 (+77%). Worst year: 2008 (-46%).
Merck Financial Breakdown (FY 2025)
Source: Yahoo Finance — MRK annual filings (2025) →$65.0B revenue · $22.1B operating income · $18.3B net income
- ●Operating margin: 34.0% on $65.0B in revenue.
- ●R&D is 24.3% of revenue ($15.8B).
- ●Net income margin: 28.1% — $18.3B in profit.
- ●Free cash flow: $12.4B (19.0% of revenue).
Cost / Operating Expenses
Total operating expenses $42.9B
Total
$42.9B
Capital Expenditures
$4.1B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$12.4B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Fundamentals (TTM)
Data: Financial Modeling PrepP/E
—
EPS
—
Net margin
—
ROE
—
Dividend yield
—
Debt / Equity
—
À propos de Merck
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
Historique de la capitalisation boursière de Merck (2026–2026)
Merck vs Sector Peers by Market Cap
Comparer Merck
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $335.5B | #42(↑7) | +31.1% |
| 2025 | $255.9B | #49(↓13) | +9.7% |
| 2024 | $233.2B | #36(↓3) | -6.3% |
| 2023 | $248.9B | #33(↓5) | +0.9% |
| 2022 | $246.6B | #28(↑27) | +49.8% |
| 2021 | $164.6B | #55(↓12) | +1.6% |
| 2020 | $162.0B | #43(↓12) | -7.3% |
| 2019 | $174.8B | #31(↓4) | +22.3% |
| 2018 | $142.9B | #27(↑19) | +40.2% |
| 2017 | $102.0B | #46(↓13) | -1.6% |
| 2016 | $103.6B | #33 | +15.2% |
| 2015 | $89.9B | #33(↓3) | -4.0% |
| 2014 | $93.7B | #30(↑5) | +17.1% |
| 2013 | $80.0B | #35(↓1) | +26.9% |
| 2012 | $63.0B | #34(↓2) | +13.4% |
| 2011 | $55.6B | #32(↑5) | +9.4% |
| 2010 | $50.8B | #37(↓6) | +2.9% |
| 2009 | $49.4B | #31(↓2) | +27.2% |
| 2008 | $38.8B | #29(↓5) | -45.8% |
| 2007 | $71.6B | #24(↑6) | +37.6% |
| 2006 | $52.0B | #30(↑10) | +41.5% |
| 2005 | $36.8B | #40(↓7) | +5.5% |
| 2004 | $34.8B | #33(↓16) | -28.1% |
| 2003 | $48.5B | #17(↓6) | -11.4% |
| 2002 | $54.7B | #11(↑3) | -1.3% |
| 2001 | $55.5B | #14(↓5) | -36.1% |
| 2000 | $86.7B | #9(↑6) | +41.7% |
| 1999 | $61.2B | #15(↓6) | -7.5% |
| 1998 | $66.2B | #9 | +41.5% |
| 1997 | $46.8B | #9 | +35.7% |
| 1996 | $34.5B | #9(↓1) | +24.0% |
| 1995 | $27.8B | #8(↑6) | +77.1% |
| 1994 | $15.7B | #14 |
Autres entreprises du secteur Santé
FAQ
What is Merck & Co., Inc.'s market cap?
Merck & Co., Inc. (MRK) has a market capitalization of $335.5B, making it the #42 largest company in the world by market cap.
What was Merck & Co., Inc.'s highest market cap?
Merck & Co., Inc.'s all-time high market cap was $335.5B, reached in 2026-08-17. Its highest rank was #42 in 2026.
What sector is Merck & Co., Inc. in?
Merck & Co., Inc. is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in United States.
How has Merck & Co., Inc.'s market cap changed over time?
Merck & Co., Inc. has been tracked since 2026. Its market cap has grown by 0% from $335.5B in 2026 to $335.5B today.